Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Laboratories considering AI-driven workflows should first identify the specific problem they aim to solve and assess if simpler coding solutions are sufficient. While out-of-the-box AI solutions from vendors offer a lower barrier to entry, laboratories must ensure these solutions align with their workflows and validate them in their own environments.
Two new ADLM documents provide guidance on toxicology testing for emergency departments, replacing a 2003 guideline. The documents address test menus, turnaround times, and the importance of educating ED staff on assay limitations.
A recent article in Archives of Pathology & Laboratory Medicine emphasizes the importance of gender-inclusive care in cytopathology laboratories. The authors, members of the CAP Cytopathology Committee, identify four key areas for improvement: laboratory information systems and terminology, cervicovaginal Pap test screening, HPV testing, and anal Pap test screening. They advocate for gender-inclusive data entry, understanding changes from hormonal therapy, equitable access to HPV testing, and expanding anal Pap test screening infrastructure.
November 2025—A 24-year-old female with hereditary stomatocytosis presented with a critical potassium concentration of 7.9 mmol/L. Despite ruling out common causes like hemolysis and EDTA contamination, the elevated potassium persisted, leading to a diagnosis of a PIEZ01 mutation causing potassium leakage.
November 2025—Medical shows often inaccurately portray the work of medical laboratory professionals, leading to a lack of public awareness about their importance. While some shows have depicted laboratory medicine accurately, many have misrepresented the field, perpetuating its undervaluation.
November 2025—The Color Atlas of Body Fluids: An Illustrated Field Guide Based on Proficiency Testing, second edition, features over 1,200 photographs, 70 photo galleries, 360 illustrations, and 15 videos. The atlas, which completes the CAP’s Color Atlas series, uses images from CAP’s laboratory proficiency testing, providing authenticity and real-world variability.
November 2025—A roundtable discussion on laboratory information systems (LIS) highlighted the challenges labs face in meeting increasing demands with limited resources. The conversation emphasized the need for improved interoperability, automation, and flexibility in LIS to address complex testing workflows and workforce shortages.
November 2025—Pathology Associates of San Antonio and Pathology Reference Laboratory (PRL) implemented Telcor’s revenue cycle management software to improve billing and collections. The No Surprises Act requires facilities to provide good-faith estimates of potential out-of-pocket costs, which PRL calculates based on average billed charges for specific procedures.
November 2025—Connecting with others is crucial for strengthening the pathology profession and improving patient care. This includes connecting with colleagues, patients, and other clinical partners to share ideas, resources, and expertise.
November 2025—Nicholas Barron, an osteopathic medical student, chose pathology after a personal health experience highlighted the field’s importance in diagnosis and healing. Izak B. Dimenstein supports the American Association of Pathologists’ Assistants’ definitions for pathologists’ assistants and grossing technicians, advocating for specialized training and certification programs to ensure quality assurance in surgical pathology.
